Apparatus and method for treating rheumatoid and psoriatic arthritis
OwnerDonald A. Diamondinventor
Life of this patent
Estimating the term…
Abstract
An apparatus and method for irradiating an inflamed joint of a patient having rheumatoid or psoriatic arthritis are presented. A noncoherent source of radiation having a predetermined wavelength range is utilized to transilluminate affected tissues of the subject for a predetermined duration. The radiation source has sufficient intensity and is applied for sufficient duration to reducing inflammation and substantially halt disease progression.
Claims5
A method of treating an inflamed joint of a patient having rheumatoid or psoriatic arthritis, comprising the steps of:
- providing a source of noncoherent radiation having an output wavelength between 640 and 800 nm and an incident power of 40 to 200 mW/cm.sup.2 ;
- and
- irradiating an epidermal surface transversely to transilluminate the inflamed joint with the radiation for a time sufficient to reduce the inflammation of the joint, the time generally in the range of 10 to 20 minutes.
A method of treating an inflamed joint of a patient having rheumatoid or psoriatic arthritis, comprising the steps of:
- providing a source of radiation and optical means that produces first a converging, then a diverging, beam with a predetermined bandwidth that includes a wavelength range of 640 to 800 nm;
- filtering all wavelengths in the convergent, then divergent, beam that lie outside the wavelength range;
- directing the filtered beam at an epidermal surface transverse to the inflamed joint;
- and
- reducing the joint inflammation by irradiating the inflamed joint with the filtered beam with an incident power of 40 to 200 mW/cm.sup.2 to reduce the inflammation, the irradiation presenting the epidermal surface with a total incident energy.
A method of treating rheumatoid and psoriatic arthritic inflammation in the body of a subject, the method comprising the steps of:
- providing a radiation source that produces first a converging, then a diverging beam with wavelengths having a bandwidth in the range of 640 to 800 nanometers;
- converging the beam;
- filtering all wavelengths outside the wavelength bandwidth while the beam is converging then diverging;
- directing the filtered radiation at the epidermis of the subject adjacent the arthritic inflammation;
- and
- reducing the arthritic inflammation by maintaining the radiation output at an incident power on the order of between about 40 to 200 milliwatts per square centimeter for a time sufficient to provide an effective treatment but not to exceed 150 joules per square centimeter when the output of the radiation source transilluminates the affected soft tissues.
Dependencies are inferred from the claim text.